How to Inject Retatrutide

Summary: Retatrutide is a once-weekly subcutaneous injection. Reconstitute the lyophilized vial with bacteriostatic water, calculate units from the resulting concentration, draw on a U-100 insulin syringe, and inject at 90 degrees into abdomen, thigh, or upper arm with weekly site rotation.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

Retatrutide is a once-weekly subcutaneous injection. If you have a vial of lyophilized powder, you reconstitute it with bacteriostatic water, draw the calculated number of units on a U-100 insulin syringe, and inject at a 90 degree angle into the abdomen, the outer thigh, or the back of the upper arm. Rotate sites every week. That is the entire procedure. Everything below is the math, the sterile technique, and the safety context that protect you from the predictable ways this goes wrong.

Before any of that: retatrutide is not FDA approved. As of May 2026 it is still an investigational drug, in phase 3 trials under the TRIUMPH program run by Eli Lilly. There is no licensed retatrutide pen, no licensed retatrutide vial, no pharmacy in the United States that can legally dispense it for human use. Every vial you see for sale online is sold as a research chemical, not a medicine, and is not produced under FDA pharmaceutical manufacturing standards. This page exists because people are injecting it anyway, and a bad procedure is more dangerous than an informed one.

Quick reference: the full procedure in eight steps

1. Reconstitute the lyophilized vial with bacteriostatic water at a concentration that makes the math easy. 10 mg powder plus 2 mL BAC water gives 5 mg/mL.
2. Let the powder fully dissolve. No shaking. Gentle swirl.
3. Calculate units. Units on a U-100 syringe equal mg dose divided by concentration, times 100.
4. Wash hands. Wipe the vial stopper with a fresh alcohol pad.
5. Draw the calculated units into a U-100 insulin syringe. Flick out air. Re-verify the unit mark.
6. Pick an injection site: abdomen at least 5 cm from the navel, outer mid-thigh, or back of upper arm. Rotate from last week.
7. Wipe the site, pinch the skin if you are lean, insert the needle at 90 degrees, push the plunger steady for five seconds.
8. Cap into a sharps container. Log the date, dose, site, and unit count.

Reconstitution: the step most people get wrong

Research-grade retatrutide ships as a lyophilized (freeze-dried) powder in a sealed vial. It is inert in that state and contains no liquid. You add bacteriostatic water, the powder dissolves, and the resulting solution is what you draw and inject. The volume of water you add determines the final concentration, and the concentration determines every unit calculation that follows.

Bacteriostatic water is sterile water containing 0.9 percent benzyl alcohol, which prevents microbial growth in a multi-use vial. Use bacteriostatic water, not sterile water for injection. Sterile water has no preservative and is intended for single-use vials only.

The standard reconstitution math:

final concentration (mg/mL) = mg of powder / mL of BAC water added

For a 10 mg vial:

Most people pick 2 mL into a 10 mg vial because 5 mg/mL produces clean unit numbers for the standard titration doses (2, 4, 8, 12 mg). A 20 mg vial reconstituted with 4 mL of BAC water lands at the same 5 mg/mL and gives you twice as many weekly doses from one vial.

How to do it:

1. Wipe the rubber stopper on the retatrutide vial and the BAC water vial with separate alcohol pads.
2. Draw your chosen volume of BAC water into a 3 mL syringe with a 23G needle.
3. Insert the needle into the retatrutide vial at an angle so the BAC water runs down the inside glass wall, not directly onto the powder. This reduces foaming.
4. Withdraw the needle. Do not shake. Swirl the vial slowly between your palms until the powder fully dissolves. The solution should be clear and colorless. If it is cloudy, contains visible particles, or has a yellow tint, do not inject.
5. Label the vial with the concentration and the reconstitution date. Refrigerate.

A reconstituted vial is generally stable refrigerated for roughly 28 to 30 days based on benzyl alcohol preservative behavior, though no formal stability data exists for research-grade retatrutide specifically. Discard at 30 days regardless of remaining volume.

Drawing the dose: U-100 insulin syringe math

A U-100 insulin syringe is calibrated so 100 units equal 1 mL. Every unit mark is 0.01 mL. This is the only kind of insulin syringe most pharmacies stock, and the only kind that lets you draw small subcutaneous volumes accurately.

The formula:

units = (mg desired / concentration in mg/mL) x 100

Worked example. Your vial is 5 mg/mL and you are prescribed a 2 mg dose.

units = (2 / 5) x 100 = 40 units

You draw to the 40 mark. That is your dose.

Another. Same 5 mg/mL vial, the titration has moved you to 4 mg.

units = (4 / 5) x 100 = 80 units

A standard 1 mL U-100 insulin syringe holds up to 100 units. An 80 unit draw fits with room to spare. If your weekly dose ever exceeds 100 units at your chosen concentration, your concentration is too low. Reconstitute the next vial with less BAC water.

The phase 2 trial published in the New England Journal of Medicine in 2023 tested retatrutide at 1, 4, 8, and 12 mg weekly, with stepwise titration starting at 2 mg ^[1]. Mean weight loss at 48 weeks reached 24.2 percent at the 12 mg dose, the largest effect ever reported for a single antiobesity drug in a phase 2 trial. Phase 3 TRIUMPH data through 2025 has reinforced that range. None of those numbers translate to you if your dose calculation is wrong.

Where to inject: the three approved subcutaneous sites

Retatrutide goes into subcutaneous fat, not muscle and not skin. There are three standard sites used across every clinical trial protocol and every GLP-1 product label that exists.

• Abdomen. Anywhere on the front of the belly at least 5 cm (about two inches) from the navel. This is the easiest site to self-inject and the site with the most predictable absorption.
• Outer thigh. The middle third of the front-outer surface of the thigh, between hip and knee. Easy to reach sitting down.
• Back of upper arm. The fatty pad on the back of the upper arm. Hard to reach for self-injection on your dominant arm. Most people use the non-dominant side and inject with their dominant hand.

All three sites produce equivalent absorption for once-weekly subcutaneous peptides. The trial protocols do not specify a preferred site, just that you use one of these three and rotate.

Sites to avoid:

• Bruised, broken, red, or tender skin.
• Within 5 cm of the navel.
• Areas with moles, scars, or visible lumps.
• Areas affected by eczema, psoriasis, or other skin conditions.
• The inner thigh (large blood vessels are close to the surface).
• Any muscle. Subcutaneous means under the skin in the fat layer, not into the muscle below.

Do you inject retatrutide into fat?

Yes. Subcutaneous means into the fatty tissue between skin and muscle. Retatrutide is formulated for subcutaneous absorption; intramuscular injection would absorb faster and unpredictably, and intradermal injection (too shallow) would leave a wheal and underdose you. The three approved sites are chosen because they have reliable subcutaneous fat in most adults.

If you are very lean and cannot pinch up a clear fold of fat at the abdomen, switch to the thigh, which generally retains subcutaneous fat even at low body fat percentages. If you cannot pinch a fold anywhere, a 4 mm or 5 mm short pen needle is safer than a longer needle because the depth limit prevents intramuscular delivery.

Step-by-step injection technique

1. Wash hands. Soap, water, twenty seconds.
2. Warm the vial. Pull from the fridge five to ten minutes before injecting. Cold peptide stings on entry.
3. Inspect the solution. It should be clear and colorless. Cloudy, particles, or color means discard.
4. Wipe the stopper. Fresh alcohol pad on the rubber top of the vial. Let dry.
5. Draw air, then liquid. Pull the syringe plunger back to your target unit mark, inject that air into the vial (this equalizes pressure and makes liquid easier to draw), then invert the vial and draw to the exact unit mark.
6. Remove air bubbles. Flick the barrel, tap the bubbles to the top, depress the plunger slightly to push them back, then re-draw to the precise mark.
7. Pick your site. Use the rotation log. Wipe the skin with alcohol. Let it dry completely. Wet alcohol stings on needle entry.
8. Pinch if needed. If you can pinch up a fat fold at the site, do it. Pinching lifts the subcutaneous layer away from muscle and is the standard technique with insulin syringes.
9. Insert at 90 degrees. Push the needle in fast and straight. An insulin needle is 6 to 8 mm long and a 90 degree insertion stays in the subcutaneous layer at any reasonable body composition.
10. Push the plunger steady. Five seconds, full depression. Hold the syringe in place for another five seconds before withdrawing to avoid leaking the dose back out.
11. Withdraw. Pull straight out. Press a clean cotton ball or gauze for a few seconds. Do not rub the site; rubbing affects absorption.
12. Dispose. Drop the entire syringe, needle attached, into a hard-sided sharps container. Never recap with your fingers.
13. Log it. Date, dose in mg, unit count, site. A note on the fridge or a phone app works. The log catches future errors before they happen.

Sterile technique: the part nobody emphasizes enough

The single largest avoidable risk with self-injected peptides is contamination. Sterile water is not actually sterile once you pierce it with a needle that has touched anything else. Bacteriostatic water tolerates one to three weeks of multi-puncture use because of the benzyl alcohol preservative; sterile water tolerates none.

Hard rules:

• New, sterile needle for every reconstitution and every injection. Needles are cheap. Infections are not.
• Fresh alcohol pad per puncture. Do not reuse one pad on multiple surfaces.
• Never inject from a vial that has been left at room temperature for extended periods after reconstitution. Refrigerate immediately.
• If you drop a needle, touch the needle to anything other than the alcohol-prepped stopper or skin, or have any doubt about sterility, discard and use a new one.
• Never share needles, syringes, or vials. Hepatitis B, hepatitis C, and HIV all transmit through shared injection equipment.

Subcutaneous abscesses from contaminated technique present as red, hot, swollen, painful nodules at the injection site that worsen over several days. If that develops, you need a clinician and possibly antibiotics. Do not ignore it.

What "not FDA quality" actually means for the vial in your hand

The FDA approval process verifies three things for any injectable: the active ingredient is what the label claims, the potency is within a narrow tolerance band of the labeled dose, and the manufacturing facility produces sterile, contaminant-free product under documented good manufacturing practice. Research-grade peptide vials skip all three of these guarantees ^[5].

What that means in practice:

• Identity. The white powder in the vial may or may not be retatrutide. Third-party mass spectrometry tests done by independent labs and forum members across the peptide market regularly find vials that contain related but incorrect peptides, underdosed product, or in some cases substances entirely unrelated to what the label claims.
• Potency. A vial labeled 10 mg may contain anywhere from 4 mg to 12 mg of actual peptide. Your calculated dose assumes the label is exact, and the label is not verified by any regulator.
• Sterility and endotoxin load. Even if the peptide is genuine, the manufacturing facility may not control bacterial endotoxin levels. Endotoxins are heat-stable bacterial cell wall fragments that survive standard sterilization and cause fever, hypotension, and inflammatory reactions when injected.

There is no licensed retatrutide pen. The phase 3 TRIUMPH trials use single-use pens that Lilly manufactures in-house for the trials only. The "retatrutide pen" devices marketed by online suppliers are repackaged research-grade vial product loaded into refillable pen bodies, not approved devices.

Oral and sublingual retatrutide do not exist as effective formulations. Retatrutide is a peptide that degrades in stomach acid, and there is no published pharmacokinetic data supporting any non-injection route. Tablets and drops sold as "oral retatrutide" do not deliver a measurable systemic dose. UK patients seeking retatrutide will not find a pill form because none exists in any clinical pipeline.

Best time and frequency

Once weekly, same day each week. The exact day does not matter. Pick a Sunday morning, a Wednesday night, whatever is consistent. Time of day does not affect absorption or efficacy in any published data, so morning versus night is your preference. Most people inject in the morning so they can monitor for any unusual reactions during waking hours, which is the only reason to prefer mornings.

If you miss a dose by less than 72 hours, take it as soon as you remember and resume your normal weekly day. More than 72 hours, skip it and take the next dose on schedule. Do not double up.

Traveling with retatrutide

A reconstituted vial needs refrigeration. For air travel, pack it in an insulated cooler with a small ice pack in your carry-on, not checked baggage (cargo holds go below freezing and ruined product is a wasted vial). TSA allows medical liquids and syringes if you declare them at security; bring documentation of your prescription if you have one. Without a prescription, syringes and unlabeled vials may attract questions you cannot answer cleanly. Lyophilized (un-reconstituted) powder is more travel-tolerant but still benefits from cool storage.

Common questions about injecting retatrutide

How do you inject retatrutide step by step?

Reconstitute the vial with bacteriostatic water, draw the calculated units on a U-100 insulin syringe, wipe an injection site on the abdomen, thigh, or back of upper arm, insert at 90 degrees, push the plunger steady for five seconds, withdraw, and log the dose.

How to administer retatrutide as a once-weekly injection?

One subcutaneous injection per week, same day each week, into abdomen, thigh, or back of upper arm. Rotate sites every dose to prevent lipohypertrophy. Time of day does not affect efficacy.

What are the best injection sites for retatrutide?

Abdomen at least 5 cm from the navel, outer mid-thigh, and back of upper arm. All three absorb equivalently. Rotate weekly. Avoid bruised, scarred, or skin-condition areas.

Do you inject retatrutide into fat or muscle?

Into the subcutaneous fat layer between skin and muscle, never into muscle. A 90 degree insertion with a 6 to 8 mm insulin needle stays in the subcutaneous layer for almost any body composition.

Is there a retatrutide pen?

No FDA-approved retatrutide pen exists. Eli Lilly uses pens internally in the phase 3 TRIUMPH trials, but those devices are not sold. Pens marketed by online suppliers are refillable bodies loaded with research-grade vial product, not approved devices.

Why is retatrutide only available as an injection, not a pill?

Retatrutide is a peptide that breaks down in stomach acid. No oral formulation has demonstrated meaningful systemic absorption in published data. Products marketed as oral or sublingual retatrutide do not deliver a measurable dose.

Is retatrutide available in pill form in the UK?

No. Retatrutide is not licensed by the MHRA or EMA in any form, oral or injectable. It is available in the UK only through enrollment in regulated phase 3 clinical trials.

Is morning or night the best time to inject retatrutide?

Either works. There is no pharmacokinetic difference. Most people choose morning so they can observe for any unusual reactions during waking hours. Consistency on the same weekday matters more than time of day.

Can I bring retatrutide on a plane?

Yes. Pack reconstituted vials in an insulated cooler with an ice pack in your carry-on. TSA permits medical liquids and syringes when declared. Bring prescription documentation if you have it.

How do I track my retatrutide doses?

Keep a log of date, dose in mg, syringe units drawn, and injection site. A note on the fridge or a phone app works. The log catches calculation errors before they compound week over week.

What size syringe do I use for retatrutide?

A 1 mL U-100 insulin syringe with a fixed 29 to 31 gauge needle, 6 to 8 mm long. This is the standard insulin syringe sold by every pharmacy. Use a new syringe for every dose.

How long is reconstituted retatrutide stable?

Roughly 28 to 30 days refrigerated, based on the bacteriostatic water preservative behavior. No formal stability data exists for research-grade retatrutide specifically. Discard at 30 days regardless of remaining volume.

What happens if I inject air?

A small air bubble in a subcutaneous injection is harmless. The risk people worry about, air embolism, requires direct intravenous air injection at large volume. Still, flick out visible bubbles before injecting for accurate dosing.

What this article does not cover

This page is the injection procedure. The reconstitution math has its own dedicated page on this site, as do retatrutide dosing schedules, the phase 2 NEJM data, the side effect profile, storage and stability, and the cost and sourcing questions. The injection technique here applies regardless of where you are in the dose escalation, just substitute your prescribed milligrams into the unit formula at the top.

If you are using retatrutide outside a clinical trial, you are making a decision the FDA has not endorsed and a clinician has not signed off on. The procedure on this page minimizes the technical risks. It does not eliminate them.